About the Primary CNS Lymphoma Session
Primary CNS lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the central nervous system, including the brain, spinal cord, and eyes. Unlike other lymphomas, it primarily manifests within the brain, leading to symptoms such as headaches, cognitive dysfunction, and vision problems. Research on PCNSL focuses on understanding its unique biology and developing targeted therapies due to its limited response to traditional treatments like chemotherapy. Recent studies delve into the genetic mutations driving its growth and potential immunotherapies that harness the body's immune system to fight cancer cells specifically within the CNS. By unraveling the intricacies of PCNSL, researchers aim to improve diagnostic methods and devise more effective treatment strategies tailored to this challenging disease.
Topics Covered in Primary CNS Lymphoma
Stereotactic Brain Biopsy
Ocular Involvement
High-Dose Chemotherapy
Autologous Transplant
Neurocognitive Outcomes
Immunocompromised Hosts
Related Scientific Sessions at CIOC 2027
Why Attend the Primary CNS Lymphoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Primary CNS Lymphoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Primary CNS Lymphoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Primary CNS Lymphoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Primary CNS Lymphoma Conference 2027 — FAQs
What is the Primary CNS Lymphoma track at CIOC 2027?
The Primary CNS Lymphoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Primary CNS Lymphoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Primary CNS Lymphoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Primary CNS Lymphoma are all welcome — whether presenting or attending.
Can I present my research in the Primary CNS Lymphoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Primary CNS Lymphoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Primary CNS Lymphoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.